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Background: Transcranial magnetic stimulation (TMS) and transcranial direct current
stimulation (tDCS) have been proposed as a new therapeutic way to enhance the
cognition of patients with dementia. However, serious methodological limitations appear
to affect the estimates of their efficacy. We reviewed the stimulation parameters and
methods of studies that used TMS or tDCS to alleviate the cognitive symptoms of
patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Moreover,
we evaluated the risk of bias in these studies. Our aim was to highlight the current
vulnerabilities of the field and to formulate recommendations on how to manage these
issues when designing studies.
Methods: Electronic databases and citation searching were used to identify studies
administering TMS or tDCS on patients with AD or MCI to enhance cognitive function.
Data were extracted by one review author into summary tables with the supervision of
the authors. The risk of bias analysis of randomized-controlled trials was conducted
by two independent assessors with version 2 of the Cochrane risk-of-bias tool for
randomized trials.
Results: Overall, 36 trials were identified of which 23 randomized-controlled trials
underwent a risk of bias assessment. More than 75% of randomized-controlled trials
involved some levels of bias in at least one domain. Stimulation parameters were highly
variable with some ranges of effectiveness emerging. Studies with low risk of bias
indicated TMS to be potentially effective for patients with AD or MCI while questioned
the efficacy of tDCS.
Conclusions: The presence and extent of methodical issues affecting TMS and tDCS
research involving patients with AD and MCI were examined for the first time. The risk of
bias frequently affected the domains of the randomization process and selection of the
reported data while missing outcome was rare. Unclear reporting was present involving
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randomization, allocation concealment, and blinding. Methodological awareness can
potentially reduce the high variability of the estimates regarding the effectiveness of TMS
and tDCS. Studies with low risk of bias delineate a range within TMS parameters seem
to be effective but question the efficacy of tDCS.
Keywords: Alzheimer’s disease, mild cognitive impairment, research methodology, transcranial magnetic
stimulation, transcranial direct current stimulation
INTRODUCTION
Non-invasive brain stimulation (NIBS) has been tested to
modify the cognition of healthy participants, as well as to
mitigate cognitive symptoms in neurodegenerative disorders
(Guse et al., 2010; Vacas et al., 2019). The two most common
forms of NIBS, namely transcranial magnetic stimulation (TMS)
and transcranial direct current stimulation (tDCS) have both
been characterized by a great variability of application and
diverse stimulation parameters. Accordingly, the results of NIBS
studies are characterized by a large amount of inter- and
intra-individual variability. This issue has led to the point
that some reviews and meta-analyses have even questioned
the efficacy of certain NIBS methods, especially tDCS, in
modulating the cognitive performance of either healthy or
demented participants (Jacobson et al., 2012; Horvath et al.,
2015). Although accumulating evidence supports the efficacy
of TMS in modulating cognition, not only the determination
of the effectiveness, but also the estimation of the effect
size is crucial which likewise needs to be based on reliable
data. Reviews indicating positive cognitive effects of NIBS in
neurodegenerative disorders have reported serious limitations of
the analyzed studies (Freitas et al., 2011; Elder and Taylor, 2014;
Hsu et al., 2015; Vacas et al., 2019). The limitations included high
heterogeneity among the applied measurements and stimulation
parameters, increased variability due to specific characteristics
among demented samples, and low statistical power resulting
from small sample sizes. All these factors might contribute to
the high variability and hinder the accurate estimation of NIBS
efficacy; however, the extent to which each of these factors is
present has not been systematically reviewed. Moreover, the
reporting of methods is often suboptimal regarding several
important design aspects of clinical trials (e.g., allocation
concealment, randomization, statistical analyses, and sample
characteristics) (Gluud, 2006). Inadequate reporting, as well as
the selection of trial design and applied methods, may affect the
estimates of NIBS effects (Savovic´ et al., 2012; Weuve et al., 2015;
Polanía et al., 2018) with a more definite influence on subjectively
assessed outcomes, such as cognitive status (Savovic´ et al., 2012).
Differences in stimulation parameters may result in the altered
efficacy of stimulation. Moreover, some settings of stimulation
parameters are designed to achieve different goals e.g., more
focal stimulation or the modulation of subcortical structures.
Consequently, clear and detailed reporting of NIBS protocols is
crucial to allow the consideration of these differences (Polanía
et al., 2018). An overview of the recommended methodological
characteristics and stimulation parameters pointing toward fully
developed methodology guidelines and consensus regarding the
elements of NIBS is needed (Weuve et al., 2015; Polanía et al.,
2018).
The current review aims to examine the presence and extent
of methodological issues confounding NIBS studies attempting
to alleviate the cognitive symptoms of demented patients. The
term cognition covers multiple domains (e.g., attention, memory,
language, decision-making, etc.), and each domain can be
assessed by numerous types of measurement. However, pooling
disparate measures that assess different constructs (i.e., different
cognitive subdomains) is generally not recommended, especially
in the presence of high heterogeneity of the intervention
(Greenfield et al., 2007). By extracting the design characteristics
and stimulation parameters of previous studies, we aim to
highlight the current vulnerabilities of the field and to formulate
recommendations on how tomanage these issues when designing
studies. We focused on original research articles that applied
repetitive transcranial magnetic stimulation (rTMS) or tDCS, i.e.,
the two most frequent NIBS techniques. We included studies
involving patients with mild cognitive impairment (MCI) and
Alzheimer’s disease (AD). AD is the most frequent form of
dementia that accounts for 50–70% of all dementia cases (Hugo
and Ganguli, 2014). Patients with MCI are in an intermediate
cognitive state, with a remarkably increased risk of conversion to
dementia compared to healthy elderly (Petersen et al., 1999). The
treatment of cognitive symptoms in AD and MCI has become an
area of major interest considering our aging population, which
increased the need for testing alternative therapeutic solutions,
such as NIBS. We argue that methodological awareness and
effort to increase the experimental control over some sources
of variability and bias would contribute to more accurate
estimations of the real effects of NIBS on cognition in dementia.
METHODS
Literature Search Strategy
Based on a recent analysis, literature search in
PubMed/MEDLINE in combination with Web of Science
leads to the recall of almost 80% of the relevant literature in
at least 80% of the reviews (Bramer et al., 2017). To further
improve this recall ratio, we searched for relevant articles also in
ScienceDirect. Therefore, the literature search of three databases
was conducted involving PubMed/MEDLINE, Web of Science,
and ScienceDirect. Furthermore, bibliographies of the retrieved
articles and the relevant reviews were hand-searched as well. The
literature search was carried out by A.H., the result of which was
confirmed by the co-authors. No review protocol or registration
details are available.
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TABLE 1 | Search keywords in PICO format.
Criteria
(PICO)
Definition Keyword
Population Patients with Alzheimer’s disease
or mild cognitive impairment
Alzheimer* disease OR
Alzheimer* dementia OR mild
cognitive impairment
Intervention TMS or tDCS to modulate
cognitive function
transcranial magnetic stimulation
OR transcranial direct current
stimulation
Comparison Control (sham) group or baseline
scores
Not set
Outcome Any measure of cognitive
function
cognition OR executive function*
OR memory OR language OR
attention
The asterisk means that the keywords were truncated.
The keywords were determined according to the PICO
(population, intervention, comparison, outcome) framework
(Schardt et al., 2007) and were searched in the full text of the
articles to increase the recall of relevant publications (Kostoff,
2010). The following keywords were applied: Alzheimer∗ disease
OR Alzheimer∗ dementia when searching for papers involving
AD patients. Mild cognitive impairment was used to identify
MCI research. For the intervention methods, the MESH terms,
transcranial magnetic stimulation OR transcranial direct current
stimulation were used. Finally, the following keywords were
applied to define outcomes: cognition OR executive function∗
OR memory OR language OR attention. These elements were
appended using AND operators (Table 1).
Eligibility Criteria
We aimed to identify original research articles examining
the effects of two NIBS techniques (either TMS or tDCS)
on any measures of cognitive function in AD or MCI
patients. Correspondingly, the following inclusion criteria were
determined prior to the literature search: (1) original research
articles; (2) written in English; (3) involving human subjects
diagnosed with AD or MCI; (4) using TMS or tDCS as
an intervention to enhance cognition and; (5) applying any
measures of cognitive function. We included clinical trials from
the start dates of the databases published until 31 December
2018. As MCI can originate from a wide range of etiological
backgrounds, we decided only to include studies that examined
MCI with no specified subgroups or MCI due to AD. We
decided not to exclude the articles that combinedNIBSwith other
interventions such as cognitive training or ongoing medication,
even without the presence of a NIBS-only condition. We argue
that the inclusion of studies with combined therapies does not
hinder the evaluation of the articles from a methodological
point of view. No criteria regarding the design of the studies
were determined. We excluded articles for (1) not reporting
empirical research; (2) not being written in English; (3) involving
animal models of dementia and; (4) not applying NIBS as an
intervention aiming to enhance cognition. Conference abstracts
and supplementary reports that were not peer-reviewed were
excluded due to their nature of limited methodological reporting.
Risk of Bias Assessment
As randomized-controlled trials (RCTs) are reported to be
particularly common in the field of NIBS (Lange et al., 2017),
we decided in advance to perform risk of bias assessment of
the identified RCTs. To assess the risk of bias in parallel-
group and crossover design RCTs, we administered Version 2
of the Cochrane risk-of-bias tool for randomized trials (RoB 2)
recommended by the Cochrane Collaboration (Higgins et al.,
2019; Sterne et al., 2019). This tool involves more domains than
other widely used scales, thus more effectively evaluating the
trials’ internal validity (Hartling et al., 2009). The five domains
of RoB 2 are (1) randomization process (selection bias), (2)
deviations from intended interventions (performance bias), (3)
missing outcome data (attrition bias), (4) measurement of the
outcome (detection bias), and (5) selection of the reported result
(reporting bias). All domains were evaluated separately and
ranked as presenting a low risk of bias, some concerns, or high
risk of bias. Three levels regarding the overall risk of bias were
possible: “Low,” containing no concerns on any of the examined
domains; “Some Concerns” involving some concerns in at least
one but less than three domains, and “High” if any of the domains
involved a high risk of bias ormore than three domains contained
some concerns. The evaluation of the studies was conducted by
two authors (AH and VLN). Any discrepancy was solved by
discussion and the consensus results are presented.
Data Extraction
Single data extraction has been found comparable with the results
of two independent data extractors in the direction, magnitude,
and precision of estimates for a great number of outcomes
(Buscemi et al., 2006); therefore, AH was responsible for the
data extraction. Data were extracted from each eligible article
regarding (1) the main characteristics of the study design and the
sample; (2) information regarding theNIBS stimulation (Table 2)
and; (3) steps to prevent bias (Table 3).
Study Characteristics, Methods, and Outcomes
We extracted information on the study design including the
intervention model and relevant study methods. The sample
size and the mean age were collected to describe the sample
characteristics. The use of the Mini-Mental State Examination
(MMSE) as a screening test was found to be a common practice,
thus we report its mean score indicating the severity of the
cognitive symptoms in the examined samples. Regarding the
outcomes, we examined the targeted cognitive domains and the
specific tests that were used to measure the given function.
The concluded results of the studies were also collected. We
examined the most important methodological characteristics of
the identified studies most of which were also evaluated during
the risk of bias assessment. We also extracted additional data
from the retrieved studies, such as the applied diagnostic criteria
for AD/MCI, as well as the time points of the applied cognitive
assessment and other aspects affecting the effect estimates (e.g.,
the use of sample size estimation). In the case of repeated testing,
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TABLE 2 | The stimulation parameters of the reviewed studies.
Study Stimulation parameters
Type of
stimulation
Target region Location and type of coil/Location and
size of electrodes
Duration Intensity of
stimulation
Frequency of
stimulation
Method of control
Studies involving patients with AD
Ahmed et al. (2012) HF and LF-rTMS Bilateral DLPFC 90mm figure-of-eight coil 5 cm rostral in the
same sagittal plane as optimal site for
MT production
5 sessions, 2,000 pulses/session 100% of RMT for
HF-TMS, 90% of
RMT for LF-TMS
1 or 20Hz Coil elevated from the scalp
Alcalá-Lozano et al.
(2018)
HF-rTMS Group 1:
LDLPFC, Group
2: 6 regions*
MCF-B70 figure-of-eight coil According to the
10–20 EEG system
15 sessions, 1,500 pulses/session 100% of RMT 5Hz No control
Cotelli et al. (2006) HF-rTMS LDLPFC and
RDLPFC
Figure-of-eight coil SofTaxic Evolution navigator
(x = ±35, y = 24, and z = 48)
1 session, 600ms from the onset of
the visual stimulus, using a train of 10
pulses, 70 stimuli
90% of RMT 20Hz Vertex stimulation with a coil
held perpendicularly
Cotelli et al. (2008) HF-rTMS LDLPFC and
RDLPFC
70mm figure-of-eight coil SofTaxic
Evolution navigator (x = ±35, y = 24, and z
= 48)
1 session, 500ms from the onset of
the visual stimulus, using a train of 10
pulses, 70 stimuli
90% of RMT 20Hz Vertex stimulation with a coil
held perpendicularly
Cotelli et al. (2011) HF-rTMS LDLPFC 70mm cooled figure-of-eight coil SofTaxic
Evolution Navigationsystem (frameless
stereotaxic neuronavigation, Talairach x = −35,
y = 24, z = 48)
10 session for 2 weeks or 20 sessions
or 4 weeks, 2,000 pulses/session
100% of RMT 20Hz Sham coil
Devi et al. (2014) HF-rTMS Bilateral DLPFC Figure-of-eight coil 5.5 cm anterior from the
location of the first dorsal interosseus
4 sessions over 2 week, 1,000
pulses/session at 10Hz or 2,000
pulses/ session at 15Hz
90% of MT 10Hz or 15Hz No control
Eliasova et al. (2014) HF-rTMS Right IFG 70mm figure-eight-shaped aircooled coil n.a. 1 session, 2,250 pulses 90% of RMT 10Hz Vertex stimulation
Haffen et al. (2012) HF-rTMS LDLPFC Air cooled figure-of-eight coil 5 cm anterior and
parasagittal line from the hand motor area
10 sessions, 2,000 pulses/session 100% of RMT 10Hz No control
Koch et al. (2018) HF-rTMS PC 70mm figure-of-eight coil Softaxic
Neuronavigation System
10 sessions, 1,600 pulses/session 100% of RMT 20Hz Sham coil
Rutherford et al.
(2015)
HF-rTMS bilateral DLPFC n.a. using fix anatomical positions Stage 1:
13 sessions (2 weeks active, 2 weeks
sham), 2,000 pulses/session
Stage 2:
10 sessions every 3 months, 2,000
pulses/session
90–100% of RMT 20Hz 2-cm wooden block
between the scalp and the
real coil
Wu et al. (2015) HF-rTMS LDLPFC Figure-of-eight coil 20 sessions, 1,200 pulses/session 80% of RMT 20Hz Tilted coil (180◦)
Zhao et al. (2017) HF-rTMS Parietal cortex
and posterior
temporal cortex
n.a. According to the 10-20 EEG system:
Parietal P3/P4 and posterior temporal T5/T6
30 sessions, 10 min/session, 10 s of
20 Hz/train, 20 s intermediate/train,
i.e., 4,000 pulses/session
10 s of 20 Hz/train,
20 s
intermediate/trainn.a.
20Hz Recorded sounds to mimic
impulses
(Continued)
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TABLE 2 | Continued
Study Stimulation parameters
Type of
stimulation
Target region Location and type of coil/Location and
size of electrodes
Duration Intensity of
stimulation
Frequency of
stimulation
Method of control
Bentwich et al. (2011) TMS-Cog 6 regions* 47–86mm figure-of-eight coil NeuroNix system 5 sessions/week for 6 weeks, 1,300
pulses/session + cognitive training for
6 weeks, then bi-weekly sessions for
3 months
90% of MT (when
stimulating Broca,
R-dlPFC
and L-dlPFC) 11%
of MT (when
stimulating
Wernicke, R-pSAC
and L-pSAC)
10Hz No control
Lee et al. (2016) TMS-Cog 6 regions* n.a. NeuroNix System 30 sessions, 1,200 pulses/session 90–110% of RMT 10Hz Recorded sounds to mimic
impulses
Nguyen et al. (2017) TMS-Cog 6 regions* Figure-of-eight coil NeuroAD system (NeuroNix) 6 weeks, 3 regions/day, 1,300
pulses/session + cognitive training
100% of RMT 10Hz No control
Rabey et al. (2013) TMS-Cog 6 regions* Figure-of-eight coil NeuroAD system (NeuroNix) 6 weeks, daily sessions 1,300
impulses/session of rTMS + cognitive
training for 6 weeks, then bi-weekly
sessions for 3 months
90% of RMT at
Broca’ area and
leftLDLPFC/right
DLPFCRDLPFC,
110% of RMT at
Wernicke, and
left/right pSAC
10Hz Sham coil
Rabey and
Dobronevsky (2016)
TMS-Cog 6 regions* Figure-of-eight coil NeuroAD system (NeuroNix) 30 sessions in 6 weeks, daily
sessions of 1,300 pulses of rTMS +
cognitive training for 6 weeks
90–110% of RMT 10Hz No control
Avirame et al. (2016) dTMS bilateral DLPFC H2-coil 6 cm anterior from the motor cortex 20 sessions, 2 or 3 times a week, 42
trains for 2 s in every 20 s, for 20min
60% of MSO 10Hz No control
Penolazzi et al. (2015) atDCS +
cognitive training
LDLPFC According to the 10-20 EEG system: anode: 5
× 7 cm, F3 cathode: 10 × 10 cm, right
supraorbital area
10 sessions, 20 min/session 2mA 10 s active stimulation
Andrade et al. (2016) atDCS LDLPFC According to the 10-20 EEG system: anode: 5
× 7 cm, F3 cathode: supraorbital area
10 sessions, 30 min/session 2mA No control
Boggio et al. (2009) atDCS LDLPFC, left
temporal cortex
According to the 10-20 EEG system: anode: 5
x 7 cm, L-DLPFC: F3, temporal cortex: T7
cathode: 5 x 7 cm, contralateral
supraorbital area
3 sessions, 30 min/session 2mA 30 s active stimulation
Boggio et al. (2012) atDCS Bilateral temporal
cortex
According to the 10-20 EEG system: anode
5×7 cm, T3, T4 cathode 8×8 cm, over the
right deltoid muscle
5 sessions, 30 min/session 2mA 30 s active stimulation
(Continued)
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TABLE 2 | Continued
Study Stimulation parameters
Type of
stimulation
Target region Location and type of coil/Location and
size of electrodes
Duration Intensity of
stimulation
Frequency of
stimulation
Method of control
Bystad et al. (2016) atDCS Left temporal
cortex
According to the 10-20 EEG system: anode:
5×7 cm, at T3 cathode: 5×7 cm, at Fp2
6 sessions, 30 min/session 2mA 30 s active stimulation
Bystad et al. (2017) atDCS Left temporal
lobe
According to the 10-20 EEG system: anode T3
cathode Fp2
Everyday sessions for 8 months, 30
min/session
2mA No control
Suemoto et al. (2014) atDCS LDLPFC anode 5×7 cm, over DLPFC cathode 5×7 cm,
right supraorbital region
6 sessions on every 2nd day, 20
min/session
2mA 20 s active stimulation
Ferrucci et al. (2008) atDCS or ctDCS Bilateral
temporoparietal
cortex
According to the 10/20 EEG system: anode
or cathode P3-T5 and P6-T4 cathode or anode
right deltoid muscle
3 sessions, 15 min/session 1.5mA 10 s active stimulation
Marceglia et al.
(2016)
atDCS or ctDCS Bilateral
temporoparietal
cortex
According to the 10-20 EEG system: anode
5×5 cm, P3-T5, P6-T4 cathode 8×8 cm, over
the right deltoid muscle
2 sessions, 15 min/session 1.5mA Comparison of atDCS and
ctDCS
Khedr et al. (2014) atDCS and
ctDCS
LDLPFC anodal: 10 x 10 cm, right supraorbital region
(10 x 10 cm) cathodal: 4 x 6 cm, left
DLPFCLDLPFC (4 x 6 cm)
10 sessions, 25 min/session 2mA 30 s active stimulation
Studies involving patients with MCI
Turriziani et al. (2012) LF rTMS LDLPFC and
RDLPFC
70mm figure-of-egiht coil According to the
10-20 EEG system: F3, F4
1 session/condition, 600
pulses/session
90% of RMT 1Hz Tilted coil (no angle
mentioned)
Drumond Marra et al.
(2015)
HF-rTMS LDLPFC Figure-of-eight coil 5 cm in a parasagittal plane
parallel to the point of maximum rMT
10 sessions, 2,000 pulses/session 110% of RMT 10Hz Sham coil
Padala et al. (2018) HF-rTMS LDLPFC Figure-of-eight coil n.a. 10 sessions/condition, 3,000
pulses/session
120% of RMT 10Hz Sham coil
Sole-Padulles et al.
(2006)
HF-rTMS LDLPFC Double-cone coil 5 cm anterior from the point
of maximum MT
1 session, 3,000 pulses 80% of MT 5Hz Coil positioned tangentially
Cotelli et al. (2012) HF rTMS Left inferior
parietal lobule
70mm cooled coil SofTaxic Evolution
navigator system (x = −44, y = −51, z = 43)
10 sessions, 2,000 pulses/session 100% of RMT 20Hz No control
Cruz Gonzalez et al.
(2018)
atDCS +
cognitive
stimulation
LDLPFC According to the 10–20 EEG system: anode: 7
× 5 cm, F3 cathode: 7 × 5 cm, contralateral
deltoid muscle
number of sessions randomized (min.
1 max. 5/condition), 30 min/session
2mA 30 s of active stimulation
Meinzer et al. (2015) atDCS Left ventral IFG anode: 5×7 cm, left Brodmann areas
(BA) 44/45 cathode: 10×10 cm, right
supraorbital region
1 session, 20 min/session 1mA 30 s of active stimulation
Murugaraja et al.
(2017)
atDCS LDLPFC According to the 10-20 EEG system: anode: 5
× 7 cm, placed between F3 and FP1 cathode:
5 × 7 cm, right supra-orbital area
5 sessions, 20 min/session 2mA No control
HF-rTMS, High frequency repetitive transcranial magnetic stimulation; LF-rTMS, Low-frequency repetitive transcranial magnetic stimulation; TMS-Cog, combination of high frequency transcranial magnetic stimulation and cognitive
training; dTMS, deep transcranial magnetic stimulation; tDCS, transcranial direct current stimulation; atDCS, anodal transcranial direct current stimulation; ctDCS, cathodal transcranial direct current stimulation; DLPFC, dorsolateral
prefrontal cortex; LDLPFC, left dorsolateral prefrontal cortex; RDLPFC, right dorsolateral prefrontal cortex; IFG, inferior frontal gyrus; PC, precuneus; L-pSAC, left parietal somatosensory association cortices; R-pSAC, right parietal
somatosensory association cortices; EEG, electroencephalography; MT, motor threshold; RMT, resting motor threshold; MSO, maximum stimulator output. *Six brain regions: Broca’s area, Wernicke’s area, RDLPFC, LDLPFC, R-pSAC,
and L-pSAC.
F
ro
n
tie
rs
in
H
u
m
a
n
N
e
u
ro
sc
ie
n
c
e
|
w
w
w
.fro
n
tie
rsin
.o
rg
6
M
a
y
2
0
2
0
|V
o
lu
m
e
1
4
|
A
rtic
le
1
7
9
H
o
lc
ze
r
e
t
a
l.
N
IB
S
in
D
e
m
e
n
tia
:
M
e
th
o
d
o
lo
g
ic
a
lIssu
e
s
TABLE 3 | The methodical properties of the reviewed studies.
Study Population Research methods Outcome measures
N Mean
age
(SD)
Mean
MMSE
(SD)
Study design Time points
of cognitive
evaluation
Diagnostic criteriaRandomization Blinding Allocation
concealment
Interval scaling Practice effect Missing data
and drop-outs
Other
statistical
practices
Cognitive domain
(tests)
Results
Studies involving patients with AD
Ahmed
et al. (2012)
45 68.4 14.84 (5.5)Double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline, day 5
(post-
intervention), 1
month later, 3
months later
(follow-up)
NINCDS-ADRDA Method not specified Patients and
assessor blinded to
group assignment
Using closed
envelopes
Global cognitive
performance (MMSE),
daily activity (IADL) and
depression (GDS)
Improvement in global
cognitive performance
and daily activity in
HF-rTMS group
compared to LF and
sham groups
Alcalá-
Lozano
et al. (2018)
19 72.15
(5.15)
Group
1: 19.5
Group
2: 18.2
Single-blind,
randomized,
parallel-group study
Baseline, week
3 (post-
intervention),
week 7
(follow-up)
DSM-5, MMSE
score≧15,
GDS-Reisberg level
2–4
Method not specified Patients blinded to
the type of
stimulation
Explicitly reported
no drop-outs
A priori sample
size
calculation,
predefined
cutoff scores
indicating
clinically
significant
change
Global cognitive
performance (MMSE,
ADAS-Cog)
Improvement in global
cognitive performance
immediately after 4
weeks of treatment,
which remained 7
weeks later as well in
both groups
Cotelli et al.
(2006)
15 76.6
(6.0)
17.8 (3.7) Randomized,
sham-controlled,
crossover study
Baseline,
during
stimulation
NINCDS-ADRDA Method not specified Language (picture
[action and object]
naming)
Improvement of action
naming speed during
the stimulation of both
LDLPFC and RDLPFC
Cotelli et al.
(2008)
24 76.3 (6) Randomized,
sham-controlled,
crossover study
Baseline,
during
stimulation
NINCDS-ADRDA Method not specified Language (picture
[action and object]
naming)
Improved action naming
performance in the mild
AD group and improved
picture naming in the
severe AD group after
active stimulation
Cotelli et al.
(2011)
10 72.8
(4.95)
Double-blind,
sham-controlled,
parallel-group study
Baseline, week
2, seek 4 week
12 (follow-up)
NINCDS-ADRDA Patients and
assessor blinded to
the type of
stimulation
Global cognition
(MMSE), (IADL),
language (picture
[object, action]
naming, Battery for
Analysis of Aphasic
Deficits), auditory
sentence
comprehension
subtest
(SC-BADA)
Improvement in the
active group in auditory
sentence
comprehension
compared to baseline
or placebo (even after 8
weeks)
Devi et al.
(2014)
10 73.1
(7.9)
25.1 (5.8) Single-arm,
open-label study
Baseline, week
2 (post-
intervention),
week 4
(follow-up)
NINCDS-ADRDA Allocation based on
the order of
recruitment
Global cognition
(MMSE), language
(BDAE)
Immediate
improvement in verbal
agility and delayed
improvement in
nonverbal agility
(Continued)
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TABLE 3 | Continued
Study Population Research methods Outcome measures
N Mean
age
(SD)
Mean
MMSE
(SD)
Study design Time points
of cognitive
evaluation
Diagnostic criteriaRandomization Blinding Allocation
concealment
Interval scaling Practice effect Missing data
and drop-outs
Other
statistical
practices
Cognitive domain
(tests)
Results
Eliasova
et al. (2014)
10 72 (8) 23 (3.56) Randomized,
sham-controlled,
crossover study
Baseline, retest
within 30min
Not defined Method not specified Tasks practiced
before trial
commencement
Global cognitive
performance (ACE-R,
MMSE), memory
(RCFT, WMS-III),
attention,
psychomotor speed,
working memory
(Stroop task, TMT-A),
executive functions
(TMT B, verbal fluency
tasks)
Enhancement of
attention and
psychomotor speed
after right IFG
stimulation after active
stimulation
Haffen et al.
(2012)
1 75 20 Case study 4 months
before
intervention
(baseline), 1
month after
stimulation
period, 5
months after
stimulation
period
(follow-up)
NINCDS-ADRDA Baseline 4
months prior the
commencement
of stimulation
period
Executive function
(Isaacs Set Test),
episodic memory
(Memory Impairment
Screen, Free and
Cued Recall Test,
Isaacs Set Test),
information processing
(TMT-A), visuospatial
skills (copying
geometric figure),
naming
Improved performance
on 8 of the 10
measures with
maintained cognitive
functioning at follow-up
Koch et al.
(2018)
14 70.0
(5.1)
26.1 (1.8) Double-blind,
randomized,
sham-controlled,
crossover study
Baseline, week
2 (post-
intervention)
Revised
NINCDS-ADRDA
criteria by Dubois
et al. (2016)
Method not specified Patients and
assessor blinded to
condition
Global cognition
(ADCS-PACC, MMSE),
attention and
psychomotor speed
(TMT) auditory verbal
learning (RAVL-T),
episodic memory
(DSST) executive
function (Modified
Card Sorting test,
Verbal fluency, FAB)
Improvement in active
group in episodic
memory, but not in
global cognition and
executive function
Rutherford
et al. (2015)
11 57–87 Double-blind,
randomized,
sham-controlled,
crossover +
open-label study
Stage 1:
baseline, week
4 (post-
intervention)
Diagnosed by
neuropsychiatrist or
neurologist or
MOCA score
between 5 and 26
Method not specified Patients and
assessor blinded,
the effectiveness to
blinding was
measured,
when assessor was
not blinded it got
reported
Alternate versions
of tasks used
Mean imputation
used and reasons
of drop-out
reported
Calculating
observed
power of tests,
average
test-retest
improvement
calculated
Global cognitive
performance and
associative memory
(ADAS-Cog, RMBC,
spatial awareness,
word–image
association)
Improvement in global
cognitive performance
in the active group
compared to sham,
especially during the
early stage of the
treatment
Wu et al.
(2015)
54 15.25
(3.1)
15.25 (3.1)Double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline, week
4 (post-
intervention)
NINCDS-ADRDA Standard table of
random numbers
Patients and
assessor blinded to
group assignment
Patients and
assessor blinded
to the group
assignment
before starting
the trial, method
not specified
Using cutoff
scores based on
the findings of
other studies
Behavioral pathology
(BPSD) and global
cognitive performance
(ADAS-Cog)
Improvement of
behavioral and global
cognitive symptoms
(Continued)
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TABLE 3 | Continued
Study Population Research methods Outcome measures
N Mean
age
(SD)
Mean
MMSE
(SD)
Study design Time points
of cognitive
evaluation
Diagnostic criteriaRandomization Blinding Allocation
concealment
Interval scaling Practice effect Missing data
and drop-outs
Other
statistical
practices
Cognitive domain
(tests)
Results
Zhao et al.
(2017)
30 70.8
(5.6)
22.5 (2.7) Prospective,
double-blind,
randomized,
sham-controlled,
parallel-group study
baseline, week
6 (post-
intervention),
week 12
(follow-up)
DSM IV Method Not specifiedPatients and
assessors blinded to
group assignment
Global cognition
(MMSE, MoCA), verbal
memory (WHO-UCLA
AVLT)
Improvement in global
cognitive performance
in the active group,
especially in mild AD
regarding memory and
language
Bentwich
et al. (2011)
8 75.4
(4.4)
22.9 (1.7) Single-arm
open-label study
Baseline 3
weeks prior
treatment, after
week 6 (post-
treatment), 4.5
months later
(follow-up)
DSM-IV criteria,
MMSE score of
18–24, CDR score
of 1
Baseline 3
weeks prior the
commencement
of stimulation
period
Drop-outs
reported and
reasoned,
managing is not
reported
Global cognitive
performance
(ADAS-cog)
Improvement in global
cognitive performance
after 6 weeks and 18
weeks
Lee et al.
(2016)
27 71.6
(6.8)
22.5 (2.7) Prospective,
double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline, week
3 (post-
intervention),
week 9
(follow-up)
DSM IV Method not specified Patients and
assessor blinded to
group assignment
Drop-outs
reported and
reasoned,
managing is not
reported
Global cognitive
performance (MMSE,
ADAS-Cog)
depression (GDS),
global function (CGIC)
Improvement in global
cognitive performance
and global functioning
after 6 weeks
compared to sham,
especially regarding
language and episodic
memory in mild AD
Nguyen
et al. (2017)
10 73.0
(7.2)
18.8 (1.9) Prospective,
single-arm,
open-label study
Baseline, week
6 (post-
intervention), 6
months later
(follow-up)
Not defined Alternate versions
of ADAS-Cog
used
Global cognitive
performance
(ADAS-Cog, MMSE,
Dubois score),
executive functions
(FAB, Stroop color
test)
Improvement in global
cognitive performance,
but it diminished after 6
months and remained
detectable only in good
responders (with high
baseline MMSE)
Rabey et al.
(2013)
15 74
(8.99)
22 (1.52) Double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline, week
6, biweekly
follow-up for 3
months
DSM-IV, MMSE
score of 18–24,
Clinical Dementia
Rating score of 1
Method not specified Patients and
assessor blinded to
group assignment
Drop-outs
reported and
reasoned,
principal
investigator
decided about
the randomness
of dropouts; last
observation was
carried forward
method
Global cognitive
performance
(ADAS-cog) and daily
activity (IADL)
Improvement in global
cognitive performance
and daily activity in HF,
compared to sham
Rabey and
Dobronevsky
(2016)
30 22.2 (0.5) Single-arm,
open-label study
Baseline, week
6 (post-
intervention)
Not defined Alternate versions
of ADAS-Cog
used
Multiple
imputation used
on missing values
with sensitivity
analyses for
observed data
only and for
worst-case
analysis, reported
the results of both
analyses
Global cognitive
performance
(ADAS-Cog, MMSE)
Improvement in global
cognitive performance
on both scales
(Continued)
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TABLE 3 | Continued
Study Population Research methods Outcome measures
N Mean
age
(SD)
Mean
MMSE
(SD)
Study design Time points
of cognitive
evaluation
Diagnostic criteriaRandomization Blinding Allocation
concealment
Interval scaling Practice effect Missing data
and drop-outs
Other
statistical
practices
Cognitive domain
(tests)
Results
Avirame
et al. (2016)
11 76 (7) Single-arm
open-label study
Baseline, 2–3
weeks later
(post-
intervention)
Diagnosed by an
expert neurologist
and confirmed by a
psychiatrist
Different stimuli
within the tasks
Missing data
reported and
reasoned,
managing is not
reported
Global cognitive
performance
(Mindstreams, ACE)
Improvement of global
cognition compared to
baseline
Penolazzi
et al. (2015)
1 60 23.2 Case study Two cycles of
baseline, week
4 (post-
intervention),
week 8
(follow-up), 2
months apart
Based on
neuropsycholgical
evaluation and
neuroimaging
Patient blind to the
stimulation, method
not specified
Comparison to
a
normative
score
Memory (Brief
Neuropsychological
Examination-2),
psychomotor speed
and executive function
(TMT A and B, clock
drawing)
Improvement on the
trained tasks whith
more enhancement
when training was
combined with active
stimulation
Andrade
et al. (2016)
1 73 Case study Baseline (1
week prior), 1
week after the
intervention
NINCDS-ADRDA Baseline 1 week
prior to the
commencement
of the stimulation
period
Global cognitive
performance
(ADAS-Cog),
neuropsychiatric
and behavioral
symptoms (NPI, DAD,
Blessed Dementia
Scale)
Improvement of global
cognitive performance,
executive function and
behavioral symptoms
compared to baseline
Boggio
et al. (2009)
10 79.1
(8.8)
17.0 (4.9) Single-blind,
randomized,
sham-controlled,
crossover study
During
stimulation
NINCDS-ADRDA Method not specified Patients blinded to
the type of
stimulation
Randomized use
of alternate
versions
Selective attention
(Stroop test, Victoria
version), working
memory (Digit span
test backward and
forward), recognition
memory (visual
memory task using
IBV software)
Improvement of visual
recognition memory
after LDLPFC and
temporoparietal
stimulation compared
to sham
Boggio
et al. (2012)
15 79.05
(8.2)
20 (3) Double-blind,
randomized,
sham-controlled,
crossover study
Baseline, day 5
(post-
treatment),
week 2, week
4 (follow-up)
NINCDS-ADRDA
and DSM-IV
Method not specified Patients and
assessor blinded to
group assignment
Randomized use
of alternate
versions of tasks
Global cognition
(MMSE, ADAS-Cog),
visual recognition
(VRT), visual attention
(VAT)
Improvement of
memory performance in
active stimulation group
Bystad
et al. (2016)
25 72.5
(8.35)
20.6 (3.35)Double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline, day 6
(post-
intervention)
Revised
NINCDS-ADRDA
Computer
randomized list
containing 5-digit
codes provided by
the manufacturer of
the tDCS device
Patients and
assessor blinded to
the type of
stimulation
Assignment
disclosed until the
end of the
intervention
Scaling according
to standardized
norm tables,
transformation to
z-scores
Two versions
of CVLT-II used
Explicitly reported
no drop-outs
Sample size
based on other
studies
Global cognitive
performance (MMSE),
Verbal learning
(CVLT-II), Attention and
executive function
(TMT, clock-drawing
test
No changes in either
cognitive function
Bystad
et al. (2017)
1 60 20 Case study Baseline, 5
months later
(during
stimulation
period), 8
months later
(post-
intervention)
Revised
NINCDS-ADRDA
Alternate versions
used
Global cognition
(RBANS)
Stabilized cognitive
decline of patient with
minor impairment of
visuospatial function
(Continued)
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TABLE 3 | Continued
Study Population Research methods Outcome measures
N Mean
age
(SD)
Mean
MMSE
(SD)
Study design Time points
of cognitive
evaluation
Diagnostic criteriaRandomization Blinding Allocation
concealment
Interval scaling Practice effect Missing data
and drop-outs
Other
statistical
practices
Cognitive domain
(tests)
Results
Suemoto
et al. (2014)
40 80.5
(7.5)
15.2 (2.85)Double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline, week
2 (post-
intervention),
week 3
(follow-up)
NINCDS-ADRDA Computer-generated
list of random
numbers
Patients and
assessor blinded to
condition, numbered
Opaque and
sealed envelopes
Reasons of
missing data not
reported,
intention to treat
analyses
conducted using
the method of last
observation
carried forward
A priori sample
size
calculation,
using the
method of
minimal
clinically
relevant
difference,
planned
pairwise
comparisons
Apathy (Apathy Scale),
global cognitive
performance (MMSE,
ADAS-Cog)
No change in active
and sham group
Ferrucci
et al. (2008)
10 75.2
(7.3)
22.7 (1.8) Double-blind,
randomized,
sham-controlled,
crossover study
baseline,
30min after
(post-
intervention)
NINCDS-ADRDA
and DSM IV
Method not specified Patients and
assessor blinded to
condition
Alternate versions
used
Recognition
memory (WRT), visual
attention (modified
Posner task)
Anodal stimulation
improved, while
cathodal stimulation
decreased word
recognition comparing
to sham
Marceglia
et al. (2016)
7 75.4
(7.2)
22.4 (1.39)Double-blind,
randomized,
crossover study
baseline,
30min later
(post-
intervention)
NINCDS-ADRDA Method not specified Alternate versions
used
Recognition
memory (WRT)
Improvement on WRT
after anodal stimulation
that correlated with
increased delta and
theta power measured
by EEG
Khedr et al.
(2014)
34 69.7
(4.8)
mild:
23–19,
moderate:
18–11
Double-blind,
randomized,
sham-controlled,
parallel-group study
baseline, end
of 10th session
(post-
intervention), 1
month and 2
months later
(follow-up)
NINCDS-ADRDA Computer generated
randomization
table
Patients and
assessor blinded to
group assignment,
the effectiveness of
blinding was
measured
Serials numbered
opaque closed
envelopes
Reportedly no
drop-outs
Global cognitive
performance
(MMSE and
WAIS-III)
Improvement in MMSE
after both anodal and
cathodal tDCS in
contrast to sham,
improvement in
performance IQ after
cathodal stimulation
Studies involving patients with MCI
Turriziani
et al. (2012)
8 66.4
(5.7)
26.9 (2) Sham-controlled,
crossover study
Criteria of Petersen
et al. (1999)
Non-verbal recognition
memory (faces and
buildings recognition)
Improvement in
non-verbal recognition
memory compared to
sham condition
Drumond
Marra et al.
(2015)
34 65.15
(3.8)
24.35
(2.05)
Double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline, week
2 (post-
intervention), 1
months later
(follow-up)
Not specified,
MoCA < 26
Computer generated
randomization
Patients and
assessors blinded to
group assignment,
the effectiveness of
blinding was
measured
Different staff
members
responsible for
the allocation
Scores
adjusted
according to
age, gender
and education
level
Everyday memory
(RBMT), global
cognitive function
(MMSE), logical
memory (WMS I, II),
memory (RAVLT),
working memory
(WAIS III),
psychomotor speed,
executive function
(TMT, verbal fluency
tasks, Victoria Stroop
Test)
Selective improvement
in everyday memory
compared to sham
group
(Continued)
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TABLE 3 | Continued
Study Population Research methods Outcome measures
N Mean
age
(SD)
Mean
MMSE
(SD)
Study design Time points
of cognitive
evaluation
Diagnostic criteriaRandomization Blinding Allocation
concealment
Interval scaling Practice effect Missing data
and drop-outs
Other
statistical
practices
Cognitive domain
(tests)
Results
Padala
et al. (2018)
6 66(9) Double-blind,
randomized,
sham-controlled,
crossover study
Baseline, week
2 (post-
intervention),
week 6 (end of
treatment-free
period), and
week 8 (post
-intervention),
week 12 (end
of
treatment-free
period)
Criteria of Petersen
et al. (1999)
Randomized block
design
Patients and
assessors blinded to
condition
Independent staff
member
responsible for
the allocation
Random subject
effect calculated
Drop-outs
reported and
reasoned
Baseline
measurements
set as
covariates
Apathy (AES-C), global
cognitive performance
(MMSE, 3MS),
executive function
(TMT, EXIT-25), global
clinical evaluation
(CGI), daily activity
(IADL, ADL)
Improvement in apathy
symptoms, global
cognition, processing
speed and clinical
improvement compared
to sham condition
Sole-
Padulles
et al. (2006)
40 67.82
(8.6)
26.33 (2.0)Double-blind,
randomized,
sham-controlled,
parallel-group study
Baseline,
immediately
after
stimulation
MMSE ≥ 24, low
performance in at
least one predefined
memory test
Patients and
assessors blinded to
condition
New stimuli used Drop-outs
reported and
reasoned
Associative memory
(face-name task)
Improvement in
associative memory
compared to sham
group
Cotelli et al.
(2012)
1 61 27 Case study Two baselines,
week 2 (post-
intervention),
week 24
(follow-up)
Criteria of Petersen
et al. (1999)
Repeated
baseline
evaluation,
comparisons to a
healthy control
group
Global cognitive
performance (MMSE),
non-verbal reasoning
(RCPM), memory
(FNAT. story recall,
AVLT, RCFT, spatial
span, digit span),
language (Token Test,
verbal fluency tasks),
praxia (De Renzi
Imitation test),
executive function
(TMT, WCST)
Improvement in
associative memory
and encoding
performance which was
maintained for 24
weeks
Cruz
Gonzalez
et al. (2018)
5 72.8
(6.65)
Single-blind,
sham-controlled,
crossover study
Screening,
week 1
(baseline),
week 2 (post-
intervention),
week 3 (post-
intervention),
week 4
(baseline)
Criteria of Portet
et al. (2006)
Order of conditions
has been kept the
same across patients
Patients blinded to
condition
Reducing the
number of
administrations of
MoCA
Missing data
reported,
managing is not
reported
Sensitivity of
the measures
is mentioned
Planning ability,
processing speed,
short-term memory,
working memory
(“Neuron Up”
tablet-based tasks,
digit span), processing
speed, attention,
executive function
(TMT), global cognitive
functioning (MoCA)
Improvement in
processing speed,
selective attention,
planning ability and
working memory
compared to sham
stimulation or cognitive
stimulation alone
(Continued)
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the management of possible practice effects was also examined
(Table 3).
Stimulation Parameters
We extracted the type of the applied NIBS method (rTMS or
tDCS). We also collected the type of stimulation (HF or LF-TMS;
anodal or cathodal tDCS or a combination of NIBS with cognitive
training). For tDCS studies, intensity and duration of the
stimulation, target region, and the location of the coil/electrode
and the positioning method. For rTMS studies, the same data
were extracted in addition to the frequency of the stimulation
and the type of the coil. In sham-controlled studies, the method
of sham was also identified.
RESULTS
Search Results
After removing the duplicates, we identified 962 articles that
underwent a thorough screening procedure (Figure 1). After the
screening of the titles, 651 records (68%) were excluded due to
not meeting the inclusion criteria. The remaining 311 records’
abstracts were screened yielding 42 studies (13%) eligible for
full-text search. At this stage, 4 studies were excluded as they
involved mixed samples of dementia patients with AD or MCI
patients not being evaluated as a separate group. Additionally,
in 2 studies only cognitive screening was administered instead
of measuring intervention-related changes, and one study used
NIBS as a diagnostic method rather than as a tool to enhance
cognition. The manual search of the included studies’ and
relevant reviews’ references did not yield any additional results.
Overall, we found 36 eligible articles that were included in the
qualitative analysis.
From the retrieved 36 studies, most involved participants
with AD (28 trials; 76%), while 8 involved MCI patients (24%).
Overall, 498 and 138 participants were recruited, respectively.
Out of the AD studies, 13 applied TMS (46%), 5 combined
TMS and cognitive training (TMS-Cog) (18%), 9 used tDCS
(32%), and one performed a combination of tDCS and
cognitive training (4%) to investigate the effects of NIBS on
a wide range of cognitive functions. Of the MCI studies, 4
applied TMS (50%), 3 administered tDCS (38%), and one
supplemented tDCS with cognitive training (12%). Furthermore,
3 research proposals were identified but will be detailed in the
discussion only.
Trial Designs
Twenty-three of the retrieved studies (64%) had an RCT design,
while 8 studies were non-RCTs (22%) and 5 were case studies
(14%). Out of the RCTs, 11 had a parallel-group (48%) and 12
involved a crossover design (52%). Out of all studies, 3 had a
prospective design, i.e., previously recruited data was analyzed.
Risk of Bias and Research Results
The risk of bias was typically present in at least one domain
in 18 of the 23 RCTs (78%). In 9 studies, some concerns
arose but less than 3 domains were affected, while 9 studies
were ranked as having an overall high risk of bias since more
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FIGURE 1 | Flow chart of the review process.
than 3 domains were affected with bias. No study implied
a high risk of bias in any domain (Figure 2). Interestingly,
studies ranked as demonstrating a low risk of bias concluded
promising clinical efficacy of TMS in both AD and MCI (Wu
et al., 2015; Padala et al., 2018) in line with those studies
with some risk of bias (for the overall assessment of studies
see Figure 3). Mixed but mostly negative results have been
found regarding the efficacy of tDCS in AD (Khedr et al.,
2014; Suemoto et al., 2014; Bystad et al., 2016) while all other
studies reported selective or overall improvement of cognition
after tDCS.
Sample Characteristics
The diagnosis of AD patients was based on theNINCDS-ADRDA
in 16 of the 28 AD studies (58%). DSM criteria were applied
in 7 studies (27%) alone or in addition to other criteria. Three
of the studies reported only that the diagnostic decision was
made by an expert (Penolazzi et al., 2015; Rutherford et al.,
2015; Avirame et al., 2016). To define MCI, various criteria were
used, including the original criteria of Petersen et al. (1999) and
its different revisions (Petersen et al., 1999; Portet et al., 2006;
Albert et al., 2011). Overall, we identified 6 studies that did
not specify how the diagnosis was established (18%) (Eliasova
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FIGURE 2 | The risk of bias of the identified studies, individually.
et al., 2014; Drumond Marra et al., 2015; Rutherford et al., 2015;
Avirame et al., 2016; Rabey and Dobronevsky, 2016; Nguyen
et al., 2017). Additional exclusion criteria were listed in almost
every study. Partly, necessary restrictions were made inherent
to the application of NIBS (e.g., no metals or stimulators in the
body) but mostly aiming to obtain a more homogeneous sample.
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FIGURE 3 | The overall risk of bias of the included studies.
Patients with severe depression and other major neurological or
psychiatric disorders were often excluded to limit the potential
sources of the observed cognitive changes. Exclusions were also
made based on the scores of cognitive screening tools to achieve
the predefined severity profile of the sample (Bentwich et al.,
2011). Strikingly, the determination of sample size was reasoned
in only 3 studies (13%) (Suemoto et al., 2014; Bystad et al., 2016;
Alcalá-Lozano et al., 2018), of which 2 conducted an a priori
sample size calculation (Suemoto et al., 2014; Alcalá-Lozano et al.,
2018). In contrast, 7 studies noted the sample size as a limitation
to their findings (30%) (Ahmed et al., 2012; Devi et al., 2014;
Eliasova et al., 2014; Murugaraja et al., 2017; Zhao et al., 2017;
Koch et al., 2018; Padala et al., 2018).
Randomization, Allocation Concealment, and
Blinding
The exact method of randomization was highly underreported
with only 8 RCTs (34%) describing the process of random-
sequence generation. Different methods were identified, such as
computer- (Suemoto et al., 2014; Drumond Marra et al., 2015)
or tDCS device-generated (Bystad et al., 2016) randomization,
the use of a table of random numbers (Khedr et al., 2014; Wu
et al., 2015) or randomized block design (Padala et al., 2018).
One study allocated patients to groups in the order of assignment
(Devi et al., 2014). Allocation concealment was reported in 7
studies, i.e., it was unclear in 70% of all RCTs. In 3 studies, opaque
envelopes were used (Ahmed et al., 2012; Khedr et al., 2014;
Suemoto et al., 2014). The DC stimulators’ built-in function, used
in one study, consists of a computer-generated list of 5-digit
codes which meant to be decrypted only after the closure of the
study, therefore, randomization and blinding are both realized
(Bystad et al., 2016). In addition, 2 studies had an independent
staff member to manage the allocation without informing the
investigators and outcome assessors (Drumond Marra et al.,
2015; Padala et al., 2018) and 2 studies stated that the allocation
was concealed without specifying its method (Wu et al., 2015;
Bystad et al., 2016). We identified 17 RCTs that were double-
blind (74%) and 2 additional studies that were single-blind to the
type of stimulation (8%). The latter usually refers to the blinding
of the participants, while double-blinding means that both the
participants and the outcome assessors are blinded. The blinding
state of the person delivering the stimulation was mentioned in
17% of the RCTs.
Cognitive Measurement and Effects of Repeated
Testing
For the evaluation of the general cognition of patients, the
cognitive subsection of the Alzheimer Disease Assessment
Scale (ADAS-Cog) and the MMSE was administered in 11
and 18 of all 28 studies (39 and 64%), respectively. The
Addenbrooke’s Cognitive Examination (ACE) was performed in
two additional studies (7%). In MCI, it was less frequent to
measure global cognition. Separate cognitive domains (language,
verbal learning, attention, working memory, executive function,
visuospatial skills, and psychomotor speed) were assessed by
various neurocognitive tests (see Table 3). Since measurements
were repeated at least once in every study, practice effects needed
to be considered. In several cases, the alternate versions of the
applied tests were performed to reduce practice effects. Two
studies failed to explicitly mention whether alternate forms of
ADAS-Cog have been used or not (Bentwich et al., 2011; Lee
et al., 2016). Additionally, in one study double baseline was
measured (Cotelli et al., 2012) and three studies measured the
baseline weeks before the commencement of NIBS (Bentwich
et al., 2011; Haffen et al., 2012; Andrade et al., 2016). Retesting
usually occurred immediately after the last session of stimulation
meaning that the interval between baseline and the first retest
varied between 5 days and 5 months in the reviewed studies.
Statistical Analysis of Results
A predefined analysis protocol was available for 7 studies (30%)
(Khedr et al., 2014; Suemoto et al., 2014; Drumond Marra et al.,
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2015; Meinzer et al., 2015; Wu et al., 2015; Bystad et al., 2016;
Padala et al., 2018) and predefined cutoff scores indicating a
meaningful change were uncommon. Moreover, whether the
statistical analysis was conducted blindly or not remained unclear
in 85% of all studies.
Stimulation Parameters
Stimulation Parameters of TMS Studies
Number of sessions
Of the identified TMS studies, 5 had a single-session paradigm
(22%), and 18 contained multiple stimulation sessions of TMS
(78%). Single-session studies often compared an active protocol
with a sham condition in an online (Cotelli et al., 2006, 2008) or
offline setting (Sole-Padulles et al., 2006; Turriziani et al., 2012;
Eliasova et al., 2014). Online single-session rTMS was performed
in two studies of Cotelli et al. (2006, 2008) to investigate its
effect on object and action naming in AD, while Eliasova et al.
(2014) examined the effect of offline TMS on a broader scale
of cognitive tasks (Cotelli et al., 2006, 2008; Eliasova et al.,
2014). Two TMS studies administered one session of either
facilitatory or inhibitory TMS in MCI patients to modulate
memory performance (Sole-Padulles et al., 2006; Turriziani
et al., 2012). Multiple-session paradigms varied in length ranging
from 5 to 30 sessions. TMS treatment lasted generally longer
than tDCS with 20 to 30 sessions being the most common in
AD and 10 sessions in MCI. The average length of multiple-
session TMS and tDCS was 16 and 7.5 sessions, respectively.
No studies administered more than 10 sessions of NIBS on
MCI patients, while 8 administered more than 10 sessions of
NIBS in AD.
Target Region, Localization Methods, and Type of the
Coil
Eight different cortical areas were targeted with NIBS of which
the DLPFC appeared to be the most favored region. DLPFC
was stimulated either unilaterally or bilaterally in 21 out of 36
studies (58%). Based on the paradigm of Bentwich et al. (2011),
several further studies involving AD participants stimulated six
brain regions, including Broca’s area, Wernicke’s area, the left
and right DLPFC (LDLPFC and RDLPFC), and the right and
left parietal somatosensory association cortices (R-pSAC and L-
pSAC) (Boggio et al., 2012; Rabey et al., 2013; Lee et al., 2016;
Rabey and Dobronevsky, 2016; Nguyen et al., 2017; Alcalá-
Lozano et al., 2018). Since the temporal cortex is one of the
first areas affected in AD (Toepper, 2017), it was targeted by 5
studies (Boggio et al., 2009, 2012; Bystad et al., 2016, 2017; Zhao
et al., 2017). The precuneus and the inferior frontal gyrus (IFG)
were also stimulated (Eliasova et al., 2014; Meinzer et al., 2015;
Koch et al., 2018). Regarding MCI, only two studies deviated
from targeting the DLPFC, one of which aimed to stimulate
the left IFG, while the other stimulated the left inferior parietal
lobule, both sides being targeted in AD as well (Cotelli et al.,
2012; Meinzer et al., 2015). TMS and tDCS studies did not differ
significantly in the choice of stimulation sites.
Of all TMS studies, figure-of-eight coil was used the most (15
studies, 77%). One study used a double-cone coil (Sole-Padulles
et al., 2006) and an H2 coil was equipped in another (Avirame
et al., 2016). The shape or type of the coil was not mentioned in
four studies (Rutherford et al., 2015; Lee et al., 2016; Zhao et al.,
2017). Likewise, the manufacturer and the type of the TMS device
was not specified in 4 studies (14%).
Neuronavigation was used in 10 TMS studies. All tDCS
studies with reported electrode localization method and 3
additional TMS studies positioned the coil/electrodes based on
the international 10–20 electroencephalography (EEG) system.
In 6 TMS studies, the coil position was calculated based on
the location of the motor cortex. When defining the DLPFC
concerning the motor hotspot, the optimal localization of the
motor cortex also varied across studies. One study named resting
motor threshold as the reference, while others used the first
dorsal interosseous, and two did not specify the exact procedure
(Ahmed et al., 2012; Haffen et al., 2012; Devi et al., 2014; Avirame
et al., 2016).
Frequency and Intensity of TMS
In the reviewed studies, TMS frequency was set at 1Hz for LF
stimulation (Ahmed et al., 2012; Turriziani et al., 2012), while
HF-TMS ranged from 5 to 20Hz. Ten and twenty hertz were the
most applied for HF-stimulation which was performed in 11 and
10 studies, respectively. Five hertz stimulation was administered
in 2 studies (Sole-Padulles et al., 2006; Alcalá-Lozano et al.,
2018), while 15Hz was used in 1 study (Devi et al., 2014).
TMS intensity varied between 80 and 120% of the resting motor
threshold (RMT). LF-TMSwas performed at 90% of RMT in both
studies. Suprathreshold stimulation (at 110 or 120% of RMT)
was administered in two HF-TMS studies. Stimulation at the
intensity of the motor threshold was performed in 7 studies. The
remaining 8 studies applied subthreshold stimulation with the
internsity of 80% or 90% of the RMT. Only one study applied
a fixed intensity, setting it to 60% of the maximum stimulation
output (Avirame et al., 2016). The number of pulses ranged from
600 to 3,000 pulses/session.
Sham Stimulation
Sham stimulation was administered in 24 studies. In TMS studies,
sham coil or other instruments to increase the distance of the real
TMS coil from the scalp were used in 6 cases (Cotelli et al., 2011;
Rabey et al., 2013; Drumond Marra et al., 2015; Rutherford et al.,
2015; Koch et al., 2018; Padala et al., 2018). Two studies placed
the real coil over the targeted area but did not apply magnetic
stimulation and prerecorded clicking sounds of the TMS device
were played instead (Lee et al., 2016; Zhao et al., 2017). Changing
the coil position such as elevating or tilting it was chosen in 4
studies (Sole-Padulles et al., 2006; Ahmed et al., 2012; Turriziani
et al., 2012; Wu et al., 2015). Another possible method is the
stimulation of an unrelated control site, e.g., the vertex, indeed
applied by 3 studies as the sham procedure (Cotelli et al., 2006,
2008; Eliasova et al., 2014). Two of these studies performed vertex
stimulation with the coil held perpendicularly, thus actually not
administering active stimulation over the vertex (Cotelli et al.,
2006, 2008).
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Stimulation Parameters of tDCS Studies
Number of sessions
Of the identified tDCS studies, 4 had a single-session paradigm
(31%), and 9 contained multiple stimulation sessions (69%).
In single-session studies, an active tDCS protocol was often
compared to a sham condition in an online (Boggio et al., 2009;
Meinzer et al., 2015) or offline setting (Ferrucci et al., 2008).
Single-session anodal, cathodal, and sham tDCS were also tested
to examine their effects on a word recognition task (Ferrucci
et al., 2008; Marceglia et al., 2016). Anodal tDCS (atDCS)
over two cortical regions were compared to sham stimulation
attempting to reduce the cognitive symptoms of AD patients
(Ferrucci et al., 2008; Boggio et al., 2009, 2012). In addition,
single-session atDCS was performed onMCI patients to examine
its effects on a range of cognitive functions (Meinzer et al., 2015).
One study compared single sessions of two active tDCS protocols
(Marceglia et al., 2016).
The duration of tDCS appeared to be shorter than TMS
treatment ranging from 1 to 10 sessions in the case of both patient
populations. The average length of multiple-session tDCS 7.5
sessions. A notable exception was a case study in which atDCS
was applied every day for 8 months (Bystad et al., 2017).
Target region and localization methods of tDCS studies
TMS and tDCS studies did not differ significantly in the
choice of stimulation sites. For summarization of target regions
and localization methods see the subsection Target Region,
LocalizationMethods, and Type of the Coil. The manufacturer of
the tDCS device was not recorded in more than half of the tDCS
studies (6 of 14, 43%).
Frequency and intensity of tDCS
Intensity appears more unified in tDCS research than in TMS
studies as it was set to 2mA in 9 of 12 studies (75%), and to 1mA
in the remaining 3 studies (25%). The duration of one session
ranged from 10 to 30min with the longer stimulation periods
being more frequent.
Sham stimulation
The most frequently used sham condition involves a short
stimulation period (usually 30 s or less). Among the articles
reviewed here, 6 mentioned the use of 30 s of stimulation (Boggio
et al., 2009, 2012; Khedr et al., 2014; Meinzer et al., 2015; Bystad
et al., 2016; Cruz Gonzalez et al., 2018), while 3 studies chose
shorter intervals, 10 or 20 s as sham stimulation (Ferrucci et al.,
2008; Suemoto et al., 2014; Penolazzi et al., 2015). None of the
reviewed studies applied active tDCS over a control site.
DISCUSSION
In the current paper, we proposed to systematically review
the current methods, quality and stimulation parameters of
research, which aims to enhance cognition in AD and MCI
patients. We included data from 36 clinical trials. Several reviews
and meta-analyses have lately concluded the positive effect
of NIBS in neurodegenerative disorders (Freitas et al., 2011;
Elder and Taylor, 2014; Hsu et al., 2015; Vacas et al., 2019);
however, important limitations have been overlooked involving
the methodology and the stimulation parameters. Our goal was
to examine the extent to which these methodological issues are
present in the field, and to provide objective recommendations
on how to improve future research. The common major aim is
to gain more reliable evidence on the effectiveness of NIBS to
mitigate the cognitive symptoms in MCI or AD dementia.
Most studies seemed to support the cognitive enhancing effect
of NIBS in dementia, regardless of the risk of bias ranking.
Interestingly, examining those RCTs with a low risk of bias
offered a more elaborate picture (for the summarization of
the methods and stimulation parameters of these studies see
Table 4). Three high-quality studies performing HF-TMS with a
figure-of-eight coil over the LDLPFC supported the enhancing
effect of TMS on cognition in AD and MCI. It is noteworthy
that parameters such as the number of sessions, the intensity
and the frequency of the stimulation differed across these
studies to some extent. Suprathreshold stimulation on 10Hz
was administered to MCI patients, while the stimulation of AD
patients was conducted at 80% of RMT with a frequency of
20Hz. Since systematic comparisons are lacking regarding these
parameters, it is hard to reason which should be preferred. Some
evidence indicates that the prefrontal cortices might require
higher stimulation intensity than the motor cortex (Thomson
et al., 2011). However, cognitive improvements in dementia
were observed when applying a range of parameters covering
subthreshold and suprathreshold intensities as well.
While the beneficial effects of TMS were further supported,
mixed results were found regarding the efficacy of tDCS. Albeit
all studies with a moderate or high risk of bias were optimistic
regarding the efficacy of tDCS, Khedr et al. (2014) have found
the facilitatory effect of both anodal and cathodal tDCS, whereas
two high-quality studies have not found any effect of tDCS on
cognition in dementia (Suemoto et al., 2014; Bystad et al., 2016).
Although all three studies stimulated AD patients recruited based
on similar criteria and each used tDCS on 2mA intensity, two
different brain areas (LDLPFC and left temporal cortex) were
stimulated. In addition, the duration of the stimulation and
the overall number of sessions was different as well. The only
study with a low risk of bias that detected a cognitive change
applied the highest number of sessions (10 sessions) and a
relatively long session duration (25 min/session) compared to
the other high-quality studies (for a summarization see Table 4).
Despite the evidence available on the effects of intensity and
duration on the excitability of the motor cortex (Agboada et al.,
2019), optimal parameters for stimulating cognition are currently
lacking. However, tDCS studies with low risk of bias featured
deviations of effects from the hypothesized direction and null
results. It indicates that NIBS effect estimates might be prone to
the confounding factors in studies with less experimental rigidity.
More than 75% of RCTs involved some levels of bias in
at least one domain, according to our risk of bias assessment.
The most affected domains were the randomization process
and the selection of the reported data. Unclear reporting was
also observable which involved the allocation concealment, the
randomization, the method of blinding, and the managing of
drop-outs. Although the risk of bias in non-RCTs was not
Frontiers in Human Neuroscience | www.frontiersin.org 18 May 2020 | Volume 14 | Article 179
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TABLE 4 | Summarization of the identified studies with low risk of bias.
Study Population Stimulation parameters Research methods Results
Type of
stimulation
Target
region
Location
and type of
coil /
Location
and size of
electrodes
Duration Intensity of
stimulation
Frequency
of
stimulation
Method of
control
Diagnostic
criteria
Randomization Blinding Allocation
concealment
Interval
scaling
Practice
effect
Missing
data and
drop-outs
Other
statistical
practices
Bystad et al.
(2016)
AD atDCS Left
temporal
cortex
According to
the 10-20
EEG system:
anode:
5×7 cm, at
T3
cathode:
5×7 cm, at
Fp2
6 sessions,
30
min/session
2mA 30 s active
stimulation
Revised
NINCDS-
ADRDA
Computer
randomized list
containing 5-digit
codes provided
by the
manufacturer of
the tDCS device
Patients and
assessor
blinded to the
type of
stimulation
Assignment
disclosed
until the end
of the
intervention
Scaling
according
to
standardized
norm
tables,
transformation
to
z-scores
Two versions
of CVLT-II
used
Explicitly
reported no
drop-outs
Sample size
based on
other studies
No changes
in global
cognition,
verbal
learning,
attention or
executive
function
Khedr et al.
(2014)
AD atDCS and
ctDCS
LDLPFC Anodal: 10 x
10 cm, right
supraorbital
region
cathodal: 4 x
6 cm,
LDLPFC
10 sessions,
25
min/session
2mA 30 s active
stimulation
NINCDS-
ADRDA
Computer
generated
randomization
table
Patients and
assessor
blinded to
group assignment
the
effectiveness of
blinding
was measured
Serials
numbered
opaque
closed
envelopes
Reportedly
no
drop-outs
Improvement
in MMSE after
both anodal
and cathodal
tDCS in
contrast to
sham,
improvement
in
performance
IQ after
cathodal
stimulation
Suemoto
et al. (2014)
AD atDCS LDLPFC Anode
5×7 cm,
over DLPFC
cathode
5×7 cm,
right
supraorbital
region
6 sessions
on every 2nd
day, 20
min/session
2mA 20 s active
stimulation
NINCDS-
ADRDA
Computer-
generated list of
random numbers
Patients and
assessor
blinded to
condition,
numbered
Opaque and
sealed
envelopes
Reasons of
missing
data not
reported,
intention to
treat
analyses
conducted
using the
method of
last
observation
carried
forward
A priori
sample size
calculation,
using the
method of
minimal
clinically
relevant
difference,
planned
pairwise
comparisons
No change in
active and
sham group
Wu et al.
(2015)
AD HF-rTMS LDLPFC Figure-of-
eight
coil
20 sessions,
1,200
pulses/session
80% of RMT 20Hz Tilted coil
(180◦ )
NINCDS-
ADRDA
Standard table of
random numbers
Patients and
assessor
blinded to
group
assignment
Patients and
assessor
blinded to
the group
assignment
before
starting the
trial, method
not specified
Using
cutoff
scores
based on
the
findings of
other
studies
Improvement
of behavioral
and global
cognitive
symptoms
(Continued)
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TABLE 4 | Continued
Study Population Stimulation parameters Research methods Results
Type of
stimulation
Target
region
Location
and type of
coil /
Location
and size of
electrodes
Duration Intensity of
stimulation
Frequency
of
stimulation
Method of
control
Diagnostic
criteria
Randomization Blinding Allocation
concealment
Interval
scaling
Practice
effect
Missing
data and
drop-outs
Other
statistical
practices
Drumond
Marra et al.
(2015)
MCI HF-rTMS LDLPFC Figure-of-
eight coil
5 cm in a
parasagittal
plane parallel
to the point
of maximum
rMT
10 sessions,
2,000
pulses/session
110% of RMT 10Hz Sham coil Not specified,
MoCA < 26
Computer
generated
randomization
Patients and
assessors
blinded to
group
assignment,
the
effectiveness of
blinding was
measured
Different staff
members
responsible
for the
allocation
Scores
adjusted
according to
age, gender
and
education
level
Selective
improvement
in everyday
memory
compared to
sham group
Padala et al.
(2018)
MCI HF-rTMS LDLPFC Figure-of-
eight coil
n.a.
10
sessions/condition,
3,000
pulses/session
120% of RMT 10Hz Sham coil Criteria of
Petersen et al.
(1999)
Randomized
block design
Patients and
assessors
blinded to
condition
Independent
staff member
responsible
for the
allocation
Random
subject effect
calculated
Drop-outs
reported
and
reasoned
Baseline
measurements
set as
covariates
Improvement
in apathy
symptoms,
global
cognition,
processing
speed and
clinical
improvement
compared to
sham
condition
AD, Alzheimer’s disease; MCI, mild cognitive impairment; HF-rTMS, high frequency repetitive transcranial magnetic stimulation; atDCS, anodal transcranial direct current stimulation; ctDCS, cathodal transcranial direct current stimulation;
LDLPFC, left dorsolateral prefrontal cortex; NINCDS-ADRDA, National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer’s Disease and Related Related Disorders Association; RMT, resting motor threshold;
EEG, electroencephalography; CVLT-II, California Verbal Learning Test-II; MMSE, Mini-Mental State Examination; MOCA, Montreal Cognitive Assessment Test.
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assessed systematically, most of them explicitly set the goal
of measuring the efficacy of NIBS. In this case, the lack of
sham-control and blinding is a major methodical drawback
that confounds the results. On the other hand, case studies
allow investigating new and more unique protocols, such as the
strikingly long stimulation period of 8 months of Bystad et al.
(2017).
A considerable amount of variance was detected between
studies applying either TMS or tDCS present concerning the
number of sessions, the stimulation duration and intensity, the
choice and location of target regions, and the type of sham
stimulation. It has been emphasized that due to the diversity of
protocols, studies are less comparable, and it is more difficult to
evaluate the underlying causes of the results (Chang et al., 2018).
We attempted to synthesize these studies to determine a range
of stimulation parameters that seem to be effective in treating
cognition of AD and MCI patients. Also, we introduced some
options that might guide the design of new research.
Recommendations on Design and
Methodology
The design should always be chosen depending on the
research question and considering its specific advantages
and disadvantages. Non-RCTs may be less optimal to
evaluate the effectiveness of a stimulation protocol compared
to RCTs; however, they can help in understanding the
feasibility of new paradigms. RCTs are considered the
gold standard of study designs. Some drawbacks of them
are the ethical considerations of the formation of some
groups (e.g., a control group of demented patients left
without rehabilitation is unacceptable) and the under-
representativeness of specific comorbidities, aggressive
behavior and minorities of the target population (Cohen-
Mansfield et al., 2014). On the other hand, homogenous
sampling reduces the variability of the studied factors, thus
introduces higher statistical power. Parallel-group RCTs
require a higher sample size than crossover-design studies;
although, the blinding of NIBS condition in the latter design is
more vulnerable.
Clear reporting is essential and should involve: (1) the method
of randomization, (2) the allocation concealment, (3) whether the
participants, their caregivers, the staff delivering the stimulation,
the outcome assessors and the person conducting the statistical
analysis were blind to the type of NIBS, (4) the occurrence, reason
and management of missing data points or drop-outs, and (5)
whether statistical analysis plan was predefined and what tests
were conducted. While different guidelines repeatedly urge the
improvement of reporting, it remains a serious issue in clinical
trials (MacPherson et al., 2010; Schulz et al., 2010).
Randomization, blinding, and allocation concealment are all
feasible methods to reduce information bias in studies with the
appropriate design. Allocation concealment was found strongly
underreported here and in other reports; due to which its effect
on the results is hard to estimate (Savovic´ et al., 2012). The
lack of proper blinding seems to be one of the most influential
sources of information bias, leading to the overestimation of the
intervention by 13% on average (Savovic´ et al., 2012). To avoid
information bias, a viable solution is to have an independent staff
member delivering the intervention who is not involved with
other stages of the research. The built-in function of tDCS is also
a great option for randomization and blinding.
It must be stated that blinding is not as straightforward as
it may seem in NIBS trials (Kessler et al., 2012; Fonteneau
et al., 2019). Skin redness or on the contrary, the lack of skin
sensations during NIBS might alleviate the effective blinding
of patients and assessors as well, to some extent. Reflecting on
this issue, some sham TMS methods incorporate prerecorded
sounds to mimic TMS pulses (Zhao et al., 2017), or weak electric
stimulation of the scalp to reproduce skin sensations; although,
participants with previous experience with TMSmight be hard to
blind even with these methods (Mennemeier et al., 2009). Vertex
stimulation has been proposed as another solution that has been
supported by a recent study (Jung et al., 2016). According to
functional neuroimaging results, vertex stimulation does not
result in elevated activation of the stimulated site; however, a
widespread decrease of brain areas related to the default brain
network has been observed. This effect might be reduced by
tilting the coil; thus, reducing the effectiveness (but also the
induced skin sensations) of the stimulation. This approach has
been chosen by some of the reviewed studies too (Cotelli et al.,
2006, 2008). To provide insight into the mechanism of how active
TMS over a given brain area affects cognitive function, the use of
multiple control methods including sham NIBS and the active
stimulation of a control site has been strongly recommended
(Duecker and Sack, 2015).
Some evidence suggests that participants can distinguish the
active tDCS condition from the sham trials above chance-level,
which might be an important limitation of crossover-designed
studies (Wallace et al., 2016; Turi et al., 2019). Moreover, short-
interval active stimulation applied as a sham condition can
result in exaggerated placebo responses and has the potential
to even modulate relevant brain areas (Fonteneau et al., 2019).
This might be of interest since the sham condition in every
examined tDCS study consisted of a short duration of active
stimulation. A novel sham method involving 30–30 s of active
tDCS at the beginning and at the end of the sham stimulation to
provide more convincing sensory experiences has been described
in the protocol of Hampstead and Hartley (2015). This might
be an interesting solution assuming that 1min of stimulation
does not result in major neuronal effects. To sum up, the
blinding of NIBS is not completely without unresolved issues.
Consequently, it is strongly advised to ask participants what
they think which type of stimulation they received. Inserting
this simple procedure into the research process may validate the
blinding and in the long term, it can enhance the comparison of
different procedures.
Careful consideration is recommended prior to the selection
of the optimal testing instrument or battery. The cognitive
subsection of the Alzheimer Disease Assessment Scale (ADAS-
Cog) and the MMSE, the two most common tests we identified,
are recognized as standard instruments for assessing global
cognition in AD. The ADAS-Cog takes around 40min to
administer, while the MMSE is a substantially shorter and
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simpler tool (Hannesdóttir and Snædal, 2002). Additionally,
outstanding reliability and validity properties and reliable change
indices are available for both batteries (ADAS-Cog: 3 points and
MMSE: 2–4 points of improvement) (Hensel et al., 2007; Bossers
et al., 2012). Notably, some deficiencies have been emphasized
regarding the accuracy of both tests. Most importantly, their
sensitivity to change has found to be low (Bossers et al., 2012),
while this would be essential to capture the NIBS treatment-
related effects. Secondly, floor and ceiling effects are present
in the case of both batteries (Cano et al., 2010; Edgar et al.,
2015), and might cause problems particularly in MCI. ADAS-
Cog has been further criticized since cognitive decline indicated
by this tool cannot be considered as clinically relevant in the
elderly (Rockwood et al., 2007). To overcome these drawbacks,
alternative scoring methods have been recommended; however,
none of the identified articles mentioned or applied them (Verma
and Howard, 2012; Philipps et al., 2014; Kueper et al., 2018).
When repeated testing occurs, practice effects should not be
ignored. Alternate versions of the tasks proven not to differ from
each other in difficulty can be applied. Since it can be assumed
that practice effects decrease over time, baseline measurement
might be recorded weeks or months prior to the commencement
of NIBS therapy. However, it is not clear how long the ideal
period would be between two sessions, as practice effects seem to
persist for years in healthy adults, and remarkable practice effects
have been found in AD and in a subgroup of MCI patients as
well (Galasko et al., 1993; Gross et al., 2018). Moreover, sudden
changes in cognitive state cannot be ruled out; thus, the risk of
drop-outs might increase. Averaging two baseline measurements
might bemore viable since the strongest association appears to be
between the first two administrations of a task. Also, this method
can reduce the confounding of the fluctuations of the cognitive
state. Otherwise, practice effects may carry clinically useful
information about the prognosis of the disease in the elderly with
cognitive impairment and may be used as an indicator of the
successfulness of brain stimulation (Verma and Howard, 2012;
Weuve et al., 2015). Theta-burst stimulation (TBS), a patterned
version of rTMS, has been found to modulate practice effects in
healthy subjects (Vékony et al., 2018), and an effect of NIBS on
practice effects might be speculated in demented samples as well.
The way of handling missing data points or drop-outs should
be conducted following the available guidelines (Altman, 2009).
Moreover, researchers should predefine how missing values will
be handled beforehand. Imputation methods are encouraged to
be used; however, the last observation carried forward (LOFT) as
a sole form of analysis has been criticized and not recommended
by statisticians (Altman, 2009). Rabey et al. (2013) applied
sensitivity analysis for the observed data only and for worst-case
analysis, which is a highly suggested procedure (Carpenter et al.,
2007). Also, the results of both analyses have been reported and
evaluated, considered as the optimal way of managing missing
data according to the guide steps of Altman (2009).
The statistical analysis of the gathered data should also
gain more attention. Firstly, blinding should be maintained
throughout the statistical evaluation of the data to minimize
information bias. Secondly, clinical researchers should follow
the trends in statistics and evaluate their applicability in their
area. For instance, the “Bayesian revolution” can add meaningful
tools to revisit the results (Etz and Vandekerckhove, 2016).
Null effects (when statistically no significant difference has
been observed) should be further investigated by measuring
the strength of evidence using the Bayes factor or equivalence
testing (Lakens et al., 2018). Bayesian statistics can reinforce the
findings gathered by traditional statistical methods and support
the strength of non-significant results. Also, the results should be
made available in order to reduce publication bias and selective
reporting. Reporting null effects is especially crucial in research
involving patient populations as publication bias can lead to
the overestimation of the effect of NIBS. This might even lead
to the advancement of a less effective treatment over a more
effective one.
Recommendations on Stimulation
Parameters
Clear reporting of stimulation parameters is equally essential as
of the research methods. Little research is available comparing
different stimulation parameters; moreover, their results might
not be generally applicable (e.g., in different populations, over
different brain areas). Considering TMS, when stimulating the
motor cortex, 10Hz stimulation failed to have an effect on motor
evoked potentials (Maeda et al., 2000), while 10Hz as compared
to 15Hz TMS similarly improved the cognitive function of
AD patients (Devi et al., 2014). In addition, some stimulation
methods are developed to achieve a specific result. Different
types of coil induce electric fields that are distinctive from one
another regarding the focality and the depth of the stimulation
(Lu and Ueno, 2017) which highlights the importance of
detailed reporting.
Similarly, the position, number, and size of tDCS electrodes
might affect the focality and the target of the stimulation to
an extent (Bai et al., 2014). Extracephalic reference electrode
placement as compared to cathode placement over a cephalic
region results in higher current density in deeper brain regions
and white matter at the cost of stimulating in a more diffuse way
(Noetscher et al., 2014). Therefore, a detailed description of the
stimulation methods is essential as it provides an opportunity to
determine which brain regions might have been stimulated and
whether the stimulation was more focal, or it extended to other
brain sites. The comparison of studies with different or unknown
parameters might introduce bias to the estimates of efficacy and
the outcomes of the results.
Based on the results of the recruited studies with low or
moderate risk of bias, the following TMS parameters are most
likely within the range of effectiveness when targeting the
cognitive function of AD or MCI patients: 10 or more sessions
with 1,200–2,000 pulses per session, a frequency of 10–20Hz
for HF-TMS and 1Hz for LF-TMS, an intensity of 80–120%
of the RMT (see Figure 4). To address the heterogeneity of
the aim and parameters of these studies, a subgroup of RCTs
that administered HF-TMS with a figure-of-eight coil were
tabulated (Table 5). This set of studies got selected because of
the overwhelming popularity of facilitatory stimulation not only
in this specific field but in all fields of TMS research where
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FIGURE 4 | Summary of the stimulation parameters of TMS studies with low or moderate risk of bias. *6 brain regions: Broca’s area, Wernicke’s area, LDLPFC,
RDLPFC, R-pSAP, and L-pSAC (as in Table 2).
the therapeutic effects of the device are being investigated. The
risk of bias and the reported outcomes of these studies are
also indicated to enhance comparison. When the parameters of
these studies are taken into consideration, a similar optimum
as previously described seems to emerge: the most frequent
settings were 10 or more sessions with a mean of ∼2,000
pulses given on the 90–100% of the RMT (Figure 5 depicts
the stimulation parameters of the studies in Table 5). Setting
fixed intensity has also been proposed (Kaminski et al., 2011)
referring to the fact that individual adaptation of TMS intensities
has not yet been proven to achieve more reliable behavioral
effects. This approach was only present in one study, which
nonetheless found TMS to improve global cognition in AD
(Avirame et al., 2016). Additionally, combining facilitatory NIBS
with cognitive stimulation seems to be a promising approach as
all studies applying this approach have reported the enhancement
of cognition (Bentwich et al., 2011; Rabey et al., 2013; Lee et al.,
2016; Rabey and Dobronevsky, 2016; Nguyen et al., 2017). It
should be noted that LF stimulation was underrepresented with
only 2 out of 34 studies applying it (Ahmed et al., 2012; Turriziani
et al., 2012); thus, its effects should be further investigated.
Regarding tDCS, stimulation parameters are hard to
recommend since studies with the highest reliability questioned
the efficacy of the most common paradigm involving multiple-
session anodal (and cathodal) stimulation on 2mA intensity
(Khedr et al., 2014; Suemoto et al., 2014; Bystad et al., 2016).
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TABLE 5 | Stimulation paramterers and findings of randomized-controlled trials applying high-frequency TMS using a figure-of-eight coil.
Study Stimulation parameters Risk of bias Results
Number of
sessions
Target region Location of coil Frequency of
stimulation
Duration Intensity of
stimulation
Method of
control
Studies involving patients with AD
Cotelli et al.
(2006)
1 session LDLPFC and
RDLPFC
SofTaxic Evolution
navigator (x = ±35, y =
24, and z = 48)
20Hz 600ms from the
onset of the
visual stimulus,
using a train of
10 pulses, 70
stimuli
90% of RMT Vertex
stimulation with
a coil held
perpendicularly
High Improvement of action naming
speed during the stimulation of
LDLPFC and RDLPFC
Cotelli et al.
(2008)
1 session LDLPFC and
RDLPFC
SofTaxic Evolution
navigator (x = ±35, y =
24, and z = 48)
20Hz 500ms from the
onset of the
visual stimulus,
using a train of
10 pulses, 70
stimuli
90% of RMT Vertex
stimulation with
a coil held
perpendicularly
High Improved action naming
performance in the mild AD
group and improved picture
naming in the severe AD group
after active stimulation
Eliasova et al.
(2014)
1 session Right IFG n.a. 10Hz 2,250 pulses 90% of RMT Vertex
stimulation
High Enhancement of attention and
psychomotor speed after right
IFG stimulation after active
stimulation
Ahmed et al.
(2012)
5 sessions Bilateral DLPFC 5cm rostral in the same
sagittal plane as optimal
site for MT production
20Hz 2,000
pulses/session
100% of RMT Coil elevated
from the scalp
Some concerns Improvement in global cognitive
performance and daily activity in
HF-rTMS group compared to LF
and sham groups
Cotelli et al.
(2011)
10 session for 2
weeks or 20
sessions or 4
weeks
LDLPFC SofTaxic Evolution
Navigationsystem
(frameless stereotaxic
neuronavigation, Talairach
x = −35, y = 24, z = 48)
20Hz 2,000
pulses/session
100% of RMT Sham coil High Improvement in the active group
in auditory sentence
comprehension compared to
baseline or placebo (even after 8
weeks)
Koch et al.
(2018)
10 sessions PC Softaxic Neuronavigation
System
20Hz 1,600
pulses/session
100% of RMT Sham coil Some concerns Improvement in active group in
episodic memory, but not in
global cognition and executive
function
Rutherford et al.
(2015)
Stage 1: 13
sessions (2
weeks active, 2
weeks sham)
Stage 2: 10
sessions every
3 months
Bilateral DLPFC using fix anatomical
positions
20Hz 2,000
pulses/session
90–100% of
RMT
2-cm wooden
block between
the scalp and
the real coil
Some concerns Improvement in global cognitive
performance in the active group
compared to sham, especially
during the early stage of the
treatment
Wu et al. (2015) 20 sessions LDLPFC n.a. 20Hz 1,200
pulses/session
80% of RMT Tilted coil (180◦) Low Improvement of behavioral and
global cognitive symptoms
Studies involving patients with MCI
Drumond Marra
et al. (2015)
10 sessions LDLPFC 5cm in a parasagittal
plane parallel to the point
of maximum rMT
10Hz 2,000
pulses/session
110% of RMT Sham coil Low Selective improvement in
everyday memory compared to
sham group
(Continued)
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y. Further high-quality research is needed to explore under what
circumstances may tDCS be beneficial in dementia (for a
summarization of the stimulation parameters of tDCS studies
with low or moderate risk of bias see Figure 6).
Targeting the DLPFC is not only widely frequent but leads to
satisfactory results. However, its localization should be carefully
implemented. TMS-based definition of the DLPFC with respect
to the motor hotspot did not overlay with the anatomical
location in healthy subjects (Ahdab et al., 2016) which may
cause differences between studies even if the same brain region
was originally intended to be targeted. Localization according
to the international EEG system, on the other hand, seems
to offer a relatively sufficient approximation (Fitzgerald et al.,
2009). This method is already frequently used in tDCS studies
and might be a non-neuronavigated alternative for TMS studies
as well. Neuronavigation is common in TMS research and is
usually based on structural images of the participants’ brains.
Nonetheless, stimulation based on the functional connections
of the individual brain might be an even better approach
considering its high accuracy (Sparing and Mottaghy, 2008).
Similarly, the use of group-based as compared to individual
coordinates to establish target location is also an aspect to
be considered, as it raises further questions about stimulation
efficacy (Sparing et al., 2009).
The stimulation of multiple sites may not enhance NIBS
effectiveness as compared to targeting a more focal area. This
has been supported by the findings of Alcalá-Lozano et al. (2018)
reporting the effects of stimulation over six regions of interest
and a simple protocol over the LDLPFC similarly effective in AD
(Alcalá-Lozano et al., 2018). On the other hand, more studies
should explore the potential of stimulating other brain areas
considering the promising results of the few available studied
targeting different brain sites, and the fact that other cortical
regions are also affected in dementia (Ruan et al., 2016).
Another important aspect that needs to be considered is
that NIBS not only modulates the brain tissue underlying
the coil/electrode. Even paradigms believed to be relatively
focal such as the application of TMS using a figure-of-eight
coil might induce activation in functionally or structurally
connected brain areas (Nahas et al., 2001; Siebner et al.,
2009; Hanlon et al., 2013). Brain regions organize into brain
networks to implement various cognitive and other operations
(Pessoa, 2014). Both TMS and tDCS can modulate functional
networks of the brain which capability can be utilized for
studying and treating brain disorders (To et al., 2018). In
stroke patients, LF-TMS over the contralesional primary motor
cortex changed the functional connectivity of the related brain
network and resulted in behavioral improvement of motor
functions (Grefkes et al., 2010). Prefrontal tDCS of healthy
adult also resulted in the connectivity changes of distinct
functional networks close to the stimulation site and its
connected regions (Keeser et al., 2011). Targeting brain hubs
of those networks that are affected in dementia might lead
to new (and maybe more personalized) treatment solutions.
The idea of targeting brain hubs was supported by one of
the identified studies where atDCS of the IFG has been found
to reverse the abnormal activity of several networks and to
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FIGURE 5 | Summary of the stimulation parameters of HF-TMS studies using a figure-of-egiht coil.
improve the overall cognitive performance in MCI (Meinzer
et al., 2015).
It is poorly understood how different stimulation parameters
contribute to the outcome of the stimulation. When frequency
was kept constant, 3.125Hz stimulation over the left motor cortex
at either a subthreshold (at 90% of RTM) or a suprathreshold
(at 110% of RTM) intensity enhanced the activation of cortical
and subcortical regions of the motor (and the auditory) system
(Bestmann et al., 2004). However, when subthreshold stimulation
was administered, the magnitude of activation was lower in
the remote sites and the effect on the target area could
not be distinguished from the physiological level. Similarly,
subthreshold (at 80% of RMT) stimulation during LF-TMS has
been found to cause the drop of oxygenation level; however, to
a shorter time period than suprathreshold (at 120% of RMT)
stimulation (Thomson et al., 2012). On the contrary, different
connectivity patterns emerged when facilitatory TBS over the
LDLPFC at 90% of the RMT was compared with suprathreshold
TBS (120% of RMT) (Alkhasli et al., 2019). When the dose of
TMS was kept constant at 120% of the RMT, the effectiveness
of 10 and 20Hz rTMS over the LDLPFC was comparable in
treating the affective symptoms of patients with major depression
(DeBlasio and Tendler, 2012). These studies not only reveal
that different methods might act through different mechanisms,
but they also shed light on the diversity of how brain activity
can be operationalized. More systematic comparisons on how
the different parameters and their combinations modify the
outcome might pave the way for TMS therapies tailored to the
patient. Accordingly, it has been suggested that individualized,
connectivity-based stimulation might serve as a means to
optimize TMS efficacy (Fox et al., 2012).
Combining brain imaging and electrophysiological
techniques with NIBS methods might offer deeper insight
into the underlying mechanisms of brain stimulation. To date,
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FIGURE 6 | Summary of the stimulation parameters of tDCS studies with low or moderate risk of bias.
only a few studies of such are available and they have suggested
the reversion of abnormal brain mechanisms, observed by
both EEG and fMRI (Meinzer et al., 2015; Marceglia et al.,
2016). Additionally, new NIBS methods such as TBS, deep
TMS (dTMS), accelerated or spaced TMS and high-definition
tDCS (HD-tDCS) might be also considered to apply in future
studies. Deep cortical regions might be stimulated by applying
dTMS, with the use of specified coil configurations such as an
H-shaped coil (Bersani et al., 2013). It has been administered
in AD patients and found to be effective in improving global
cognition to a great extent and is associated with similar effects
as traditional rTMS protocols (Zafar et al., 2008; Blumberger
et al., 2018). Strikingly, only one research proposal was found
aiming to measure its effectiveness on the cognition of demented
patients. The utilization of specialized small electrodes (i.e.,
high-definition tDCS, HD-tDCS) appears to be promising as
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well and is currently tested on healthy individuals (Hampstead
and Hartley, 2015; Turski et al., 2017).
Prospects and Limitations of the Present
Review
Limitations of this review include the lack of quality assessment
of non-RCTs. However, as previous analyses have indicated
(Lange et al., 2017), the majority of the recruited studies had
an RCT design. Also, most of the identified non-RCTs aimed
to measure the cognitive effects of NIBS which is biased by the
nature of the design. Non-RCTs are more suitable to examine
the feasibility and acceptability of new protocols, and indeed
some of the studies have investigated new methods. The lack of
quantitative analysis may also be considered as a limitation of
this review. In order to quantify the results, reliable studies more
similar to each other regarding the intervention, measurements,
and the sample should be available (Greenfield et al., 2007).
The qualitative summarization presented here aims to increase
the number of such articles and to pave the way for future
quantitative meta-analyses. Some articles might not be identified
as restrictions were made regarding the language and due to not
including a gray literature search.
Our current findings on the narrower sample of TMS and
tDCS studies in AD and MCI can be expanded to other
brain stimulation methods and different types of dementias.
However, this requires the consideration of the specificities of
the given method and population. While AD and MCI mostly
differ in the severity and number of cognitive symptoms, the
cognitive profile and the trajectory of decline show significant
differences in other dementias (Smits et al., 2015). While
episodic learning is impaired in AD affecting immediate
and delayed recall and the deficit of working memory and
executive functioning is present, language skills are more
preserved as compared to frontotemporal dementia. Attention
and visuospatial dysfunctions aremore characteristic to dementia
with Lewy bodies (Sparing et al., 2009). Therefore, researchers
should consider which cognitive function to assess and train if
cognitive training is included. Also, the double baseline approach
might be considered in order to reduce the effects of fluctuating
performance which is often observable in patients with
frontotemporal dementia (Smeding and de Koning, 2000; Lange
et al., 2017). Due to these fluctuations, the number of missing
data may also increase during cognitive assessments (Smeding
and de Koning, 2000; Lange et al., 2017). As recommended above,
the management and the statistical methods to assess their effects
should be predetermined and reported.
In the present review, we considered measurements of the
cognitive domain only; however, neuropsychiatric symptoms
are considered to be closely linked with cognitive disturbances
causing reduced quality of life in neurodegenerative disorders
(Rog et al., 2014; van der Linde et al., 2016). Different scales
are used to measure neuropsychiatric symptoms in patients,
mostly applying self-report questionnaires, which introduces new
sources of bias (Althubaiti, 2016). Scales that collect information
from different sources, such as from the caregivers and/or
clinicians should be preferred (Sheehan, 2012). Moreover, these
seem to be more reliable in the presence of unclear blinding
efficacy (Wood et al., 2008).
CONCLUSION
In the present review, we described and examined for the first
time the actual presence of methodical factors that can obscure
the results when investigating the effects of NIBS in MCI and
AD. Great diversity among stimulation parameters was found,
a common characteristic of all NIBS studies in a general sense.
The risk of bias affects most of the identified studies to a various
extent. We revealed that the conclusion of studies with low risk
of bias differs from the others regarding the efficacy of NIBS.
This indicates that potential sources of bias can lead to further
distortions of the estimated effects of NIBS. Therefore, cautious
planning and rigorous implementation are highly advised with
the consideration of the aspects we collected.
At this point, based on the currently available literature,
it is difficult to conclude the effectiveness of NIBS methods
in dementia research. Nonetheless, some arguments can be
made. Our results indicate that TMS exerts more prominent
and reliable behavioral effects. Moreover, we identified a
range of TMS parameters that seem to effectively achieve
behavioral improvements based on the reviewed articles and
further evidence. Also, the combination of NIBS with cognitive
stimulation appears to be a promising approach in MCI and
AD. We argue that, with the elimination of the identified
methodological issues, the variability of results would be reduced,
their interpretation improved, and stronger conclusions could be
drawn for the future implementation of NIBS.
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